Regeneron Pharmaceuticals, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2020 | — | 42.1% | 41.3% |
| FY2021 | — | 55.7% | 50.2% |
| FY2022 | — | 38.9% | 35.6% |
| FY2023 | — | 30.9% | 30.1% |
| FY2024 | — | 28.1% | 31.1% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2020 | — | 42.1% | 41.3% |
| FY2021 | — | 55.7% | 50.2% |
| FY2022 | — | 38.9% | 35.6% |
| FY2023 | — | 30.9% | 30.1% |
| FY2024 | — | 28.1% | 31.1% |